Owens & Minor, Inc. (NYSE:OMI) SVP Sells $124,200.00 in Stock

Owens & Minor, Inc. (NYSE:OMI) SVP Jonathan A. Leon sold 5,000 shares of the firm’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $24.84, for a total value of $124,200.00. Following the transaction, the senior vice president now directly owns 84,673 shares of the company’s stock, valued at $2,103,277.32. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Owens & Minor Price Performance

OMI stock opened at $24.74 on Thursday. The company has a market capitalization of $1.90 billion, a P/E ratio of -45.81, a price-to-earnings-growth ratio of 0.77 and a beta of 0.43. The company has a debt-to-equity ratio of 2.05, a quick ratio of 0.52 and a current ratio of 1.11. Owens & Minor, Inc. has a 52-week low of $13.34 and a 52-week high of $28.35. The business has a 50-day simple moving average of $25.11 and a two-hundred day simple moving average of $21.03.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Tuesday, February 20th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.03. The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.67 billion. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The company’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.28 EPS. Research analysts expect that Owens & Minor, Inc. will post 1.54 EPS for the current fiscal year.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently modified their holdings of OMI. Zhang Financial LLC purchased a new position in Owens & Minor in the first quarter valued at approximately $261,000. LHM Inc. bought a new position in Owens & Minor during the first quarter valued at $2,628,000. Allspring Global Investments Holdings LLC grew its holdings in Owens & Minor by 43,142.9% during the first quarter. Allspring Global Investments Holdings LLC now owns 3,027 shares of the company’s stock valued at $84,000 after purchasing an additional 3,020 shares during the period. Hexagon Capital Partners LLC grew its holdings in Owens & Minor by 1,240.2% during the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after purchasing an additional 1,451 shares during the period. Finally, Riverview Trust Co bought a new position in Owens & Minor during the first quarter valued at $25,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Wall Street Analysts Forecast Growth

OMI has been the subject of several research analyst reports. Robert W. Baird lifted their price objective on Owens & Minor from $24.00 to $28.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 10th. TheStreet raised Owens & Minor from a “d+” rating to a “c-” rating in a research report on Monday, March 4th. Citigroup boosted their target price on Owens & Minor from $23.00 to $24.00 and gave the company a “neutral” rating in a research report on Wednesday, February 21st. SVB Leerink began coverage on Owens & Minor in a research report on Monday, February 26th. They issued a “market perform” rating and a $24.00 target price for the company. Finally, StockNews.com raised Owens & Minor from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $23.29.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.